AA
VIVO

Ancora Advisors’s Meridian Bioscience Inc VIVO Stock Holding History

Ancora Advisors’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-9,080
Closed -$170K – 1863
2020
Q4 		$170K Sell
9,080
-1,640
-15% -$30.6K 0.01% 655
2020
Q3 		$182K Sell
10,720
-880
-8% -$17.1K 0.01% 619
2020
Q2 		$270K Buy
+11,600
New +$168K 0.01% 548
2017
Q1 		– Sell
-260
Closed -$5K – 1128
2016
Q4 		$5K Buy
+260
New +$4.57K ﹤0.01% 1126

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Ancora Advisors's VIVO Position: Q1 2021 in Review

Ancora Advisors sold out of Meridian Bioscience Inc (VIVO) in Q1 2021, closing a stake of 9,080 shares — an estimated $170K sold.

Ancora Advisors first reported a position in VIVO in Q4 2016 and held it in 4 quarters. The position peaked at $270K in Q2 2020. 215 funds tracked by Wall St. Rank hold VIVO as of Q1 2021.

  • Ancora Advisors reported no remaining Meridian Bioscience Inc position as of Q1 2021 after selling out during the quarter.
  • Ancora Advisors sold 9,080 Meridian Bioscience Inc shares in Q1 2021, an estimated $170K.
  • Ancora Advisors first reported a position in Meridian Bioscience Inc in Q4 2016 and held it in 4 quarters.
  • Ancora Advisors's Meridian Bioscience Inc position peaked at $270K in Q2 2020.
  • 215 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2021.

Based on Ancora Advisors's 13F filing for Q1 2021, filed 14 May 2021.